A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus

Dengue virus is an important emerging pathogen, but so far there is no vaccine effective for all serotypes. Screaton and colleagues identify a class of broadly reactive human antibodies focused on an epitope that bridges two virion subunits.